Global Antibiotic Research and Development Partnership
room 15 Chemin Camille-Vidart | 1202 Geneva | Switzerland
arrow_back See all Activities

Children's Antibiotics

IATI Identifier:

Published on IATI
  • date_range Jan 01, 2017
  • autorenew Implementation (Status)

Globally, infectious diseases such as pneumonia and sepsis are the leading cause of death and disability in children under five and are responsible for more than 3 million deaths a year. The situation is worsened by drug-resistant infections, as the limited number of treatments for children and babies are becoming less effective. More than 214,000 babies die each year from drug-resistant infections. Most of these deaths occur in low- and middle-countries.

more_horiz
Sectors:
  • Medical research

Participating Organisations

UK - Department of Health and Social Care (DHSC) Government Funding
German Federal Ministry of Education and Research Government Funding
German Federal Ministry of Health Government Funding
Principality of Monaco Government Funding
South African Medical Research Council Other Public Sector Funding
Bill & Melinda Gates Foundation Foundation Funding
Wellcome Trust Foundation Funding
Leo Model Foundation Foundation Funding

Transaction

Transaction Value Provider
Receiver
Type Date
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range

Budget

2,967,404 USD
  • 2,644,767 EUR (Valued at Dec 31, 2019)
    date_range Jan 01, 2019 - Dec 31, 2019
access_time Updated on Aug 07, 2020 08:38:10